Beth Barber

Beth Barber has a diverse work experience in the pharmaceutical industry spanning over three decades. Beth'smost recent role is as the Vice President of Global Market Access and Strategic Evidence at Seagen since April 2023. Prior to that, they held leadership positions at Johnson & Johnson, including Vice President of RW Value & Evidence from May 2019 to April 2023, and Vice President of RWA&A from July 2018 to May 2019. Before joining Johnson & Johnson, Beth was the Executive Director of Global Health Outcomes at Amgen, Inc from February 2006 to June 2018. Beth also worked at Eli Lilly and Company as a Senior Manager from October 1997 to February 2006, and at Merck as a Biometrician from an undisclosed period in 1993 to 1997.

Beth Barber's education history includes a Master's degree in Mathematical Statistics and Probability from Rutgers University. Beth also holds a PhD from Temple University, although the field of study for their PhD is not specified.